Health
Swipe up to read →
A pattern is emerging across teams, products, and markets — and it changes how serious people should think about the truth about continuous glucose monitors for non-diabetics.
The shift began quietly. A handful of teams, working in parallel and mostly unaware of each other, arrived at similar conclusions: the old approach optimized for a constraint that no longer binds. Hardware got cheaper. Models got smaller.…
The shift began quietly. A handful of teams, working in parallel and mostly unaware of each other, arrived at similar conclusions: the old approach optimized for a constraint that no longer binds. Hardware got cheaper. Models got smaller.…
If you talk to the practitioners actually shipping in this space, they sound notably less excited and notably more confident than the hype cycle suggests. That contrast — quieter, more grounded enthusiasm — is usually the signal you want.…
If you take one thing away: the asymmetry has flipped. The risk used to be over-investing. Now it's under-investing while convincing yourself you're being prudent.
A pattern is emerging across teams, products, and markets — and it changes how serious people should think about the truth about continuous…